Shiva Amirizadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shiva Amirizadeh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Iraj Ragerdi Kashani
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Maedeh Hashemi
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Reza Asadi-Golshan
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Davood Zarini
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Parichehr Pasbakhsh
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Maryam Shabani
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 6 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 235
Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice
Background Multiple sclerosis (MS) results in histological alterations, which in turn leads to behavioral deficits. Bone marrow mesenchymal stem cells (BMSCs) demonstrate therapeutic potential in MS. This study aimed to assess whether intranasally delivered BMSCs improve cerebellar structure and motor function in an intermittent cuprizone-induced (INT-CPZ) MS model. Methods The mice were divided into five groups: control, CPZ, CPZ + BMSC, INT-CPZ, and INT-CPZ + BMSC. BMSCs were intranasally delivered at weeks 4 and 10. Motor performance was evaluated using beam walking, pole, and ladder rung walking tests. Stereological analyses were performed to estimate cortex and white matter volumes and Purkinje cell number. Results BMSC treatment improved motor coordination and balance, particularly in INT-CPZ + BMSC mice, which outperformed the CPZ + BMSC group. Stereological results showed reduced volume loss in cortex and white matter and higher Purkinje cell number in BMSC-treated groups, with INT-CPZ + BMSC showing the most pronounced effect. Conclusion Intranasal BMSC therapy effectively preserved cerebellar structure and motor function in cuprizone-exposed mice. Intermittent cuprizone exposure enhanced BMSC efficacy, likely through mechanisms involving neuroregeneration, and neuroprotection.
- 6 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 235
Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice
Background Multiple sclerosis (MS) results in histological alterations, which in turn leads to behavioral deficits. Bone marrow mesenchymal stem cells (BMSCs) demonstrate therapeutic potential in MS. This study aimed to assess whether intranasally delivered BMSCs improve cerebellar structure and motor function in an intermittent cuprizone-induced (INT-CPZ) MS model. Methods The mice were divided into five groups: control, CPZ, CPZ + BMSC, INT-CPZ, and INT-CPZ + BMSC. BMSCs were intranasally delivered at weeks 4 and 10. Motor performance was evaluated using beam walking, pole, and ladder rung walking tests. Stereological analyses were performed to estimate cortex and white matter volumes and Purkinje cell number. Results BMSC treatment improved motor coordination and balance, particularly in INT-CPZ + BMSC mice, which outperformed the CPZ + BMSC group. Stereological results showed reduced volume loss in cortex and white matter and higher Purkinje cell number in BMSC-treated groups, with INT-CPZ + BMSC showing the most pronounced effect. Conclusion Intranasal BMSC therapy effectively preserved cerebellar structure and motor function in cuprizone-exposed mice. Intermittent cuprizone exposure enhanced BMSC efficacy, likely through mechanisms involving neuroregeneration, and neuroprotection.
- 21 October 2025
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 29 (5) , 559-578
Hesperidin protects against sodium fluoride-induced molecular, stereological, and behavioral alterations in the rat cerebellum
Exposure to elevated levels of fluoride from environmental or dietary sources can lead to toxic effects on the nervous system. This work examined the potential of hesperidin, a citrus-derived flavonoid recognized for its neuroprotective actions, to counteract NaF-induced toxicity in the rat cerebellum. Male rats (n = 10 per group) were divided into four groups receiving either normal water, NaF (200 ppm) alone, NaF plus hesperidin (200 mg/kg/day), or hesperidin alone for 4 weeks. Neurobehavioral assessments, including the beam walking, ladder rung walking, inclined plane, and accelerating rotarod tests, were performed, followed by neurochemical and quantitative stereological analysis of the cerebellum. NaF-treated rats exhibited deficits in coordination, balance, learning, and adaptation as assessed by behavioral testing. However, co-treatment with hesperidin significantly prevented these motor deficits. Molecular findings indicated that hesperidin may have lessened NaF-induced neurotoxicity by helping to maintain brain-derived neurotrophic factor (BDNF) mRNA expression and preserving antioxidant enzyme activity [superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)], while simultaneously lowering malondialdehyde (MDA) levels and suppressing p53 expression. Stereological analysis showed that hesperidin prevented NaF-related reductions in total cerebellar, cortical, and white matter volumes, as well as in Purkinje cell number. Prolonged NaF exposure is linked to cerebellar structural alterations and motor deficits, likely mediated by oxidative stress, apoptosis, and disrupted neurotrophic signaling. In this experimental model, appeared to mitigate these effects by enhancing antioxidant defenses and supporting neuroprotective mechanisms, suggesting its potential to preserve cerebellar structure and function under fluoride-induced toxicity.
- 21 October 2025
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 29 (5) , 559-578
Hesperidin protects against sodium fluoride-induced molecular, stereological, and behavioral alterations in the rat cerebellum
Exposure to elevated levels of fluoride from environmental or dietary sources can lead to toxic effects on the nervous system. This work examined the potential of hesperidin, a citrus-derived flavonoid recognized for its neuroprotective actions, to counteract NaF-induced toxicity in the rat cerebellum. Male rats (n = 10 per group) were divided into four groups receiving either normal water, NaF (200 ppm) alone, NaF plus hesperidin (200 mg/kg/day), or hesperidin alone for 4 weeks. Neurobehavioral assessments, including the beam walking, ladder rung walking, inclined plane, and accelerating rotarod tests, were performed, followed by neurochemical and quantitative stereological analysis of the cerebellum. NaF-treated rats exhibited deficits in coordination, balance, learning, and adaptation as assessed by behavioral testing. However, co-treatment with hesperidin significantly prevented these motor deficits. Molecular findings indicated that hesperidin may have lessened NaF-induced neurotoxicity by helping to maintain brain-derived neurotrophic factor (BDNF) mRNA expression and preserving antioxidant enzyme activity [superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)], while simultaneously lowering malondialdehyde (MDA) levels and suppressing p53 expression. Stereological analysis showed that hesperidin prevented NaF-related reductions in total cerebellar, cortical, and white matter volumes, as well as in Purkinje cell number. Prolonged NaF exposure is linked to cerebellar structural alterations and motor deficits, likely mediated by oxidative stress, apoptosis, and disrupted neurotrophic signaling. In this experimental model, appeared to mitigate these effects by enhancing antioxidant defenses and supporting neuroprotective mechanisms, suggesting its potential to preserve cerebellar structure and function under fluoride-induced toxicity.
- 10 July 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (9) , 2220-2232
Impact of Sleep Deprivation on Bone Marrow Mesenchymal Stem Cell-Mediated Remyelination in the Corpus Callosum of Male Mice
- 10 July 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (9) , 2220-2232
Impact of Sleep Deprivation on Bone Marrow Mesenchymal Stem Cell-Mediated Remyelination in the Corpus Callosum of Male Mice
- 5 July 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (4) , 1-14
Impaired therapeutic efficacy of sleep-deprived bone marrow mesenchymal stem cells in the cerebellum of mouse cuprizone model of multiple sclerosis: stereological and motor behavioral evidence
Multiple sclerosis (MS) leads to histological changes, which in turn result in functional deficits. Studies have reported that bone marrow mesenchymal stem cells (BMSCs) have therapeutic benefits in MS. In addition, sleep deprivation affects therapeutic potential of BMSCs. This research aimed to evaluate the effects of BMSCs compared to sleep-deprived BMSCs (SD-BMSCs) on the motor behavior and histological recovery in MS. The mice were divided into four groups receiving cuprizone for five weeks, with or without intranasal administration of cells (BMSCs or SD-BMSCs) after five weeks. After a two-week recovery period, balance beam and pole tests were performed to assess motor performance, followed by estimation of histological parameters using stereological methods. Mice that received BMSCs scored significantly better than the SD-BMSC group in balance beam and pole tests (P < 0.05). The total cerebellar volume, cortex, and white matter volumes, as well as the total number of Purkinje cells in mice that received BMSCs, were significantly higher compared to those in the SD-BMSC group (P < 0.05). Intranasal administration of BMSCs leads to significantly improved motor behavior and histological regeneration of the cerebellum, including cortex and white matter as well as Purkinje cells compared to SD-BMSCs in a cuprizone model of multiple sclerosis.
- 5 July 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (4) , 1-14
Impaired therapeutic efficacy of sleep-deprived bone marrow mesenchymal stem cells in the cerebellum of mouse cuprizone model of multiple sclerosis: stereological and motor behavioral evidence
Multiple sclerosis (MS) leads to histological changes, which in turn result in functional deficits. Studies have reported that bone marrow mesenchymal stem cells (BMSCs) have therapeutic benefits in MS. In addition, sleep deprivation affects therapeutic potential of BMSCs. This research aimed to evaluate the effects of BMSCs compared to sleep-deprived BMSCs (SD-BMSCs) on the motor behavior and histological recovery in MS. The mice were divided into four groups receiving cuprizone for five weeks, with or without intranasal administration of cells (BMSCs or SD-BMSCs) after five weeks. After a two-week recovery period, balance beam and pole tests were performed to assess motor performance, followed by estimation of histological parameters using stereological methods. Mice that received BMSCs scored significantly better than the SD-BMSC group in balance beam and pole tests (P < 0.05). The total cerebellar volume, cortex, and white matter volumes, as well as the total number of Purkinje cells in mice that received BMSCs, were significantly higher compared to those in the SD-BMSC group (P < 0.05). Intranasal administration of BMSCs leads to significantly improved motor behavior and histological regeneration of the cerebellum, including cortex and white matter as well as Purkinje cells compared to SD-BMSCs in a cuprizone model of multiple sclerosis.